Cargando…

Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes

BACKGROUND: Cardiovascular disease and kidney damage are tightly associated in people with type 2 diabetes. Experimental evidence supports a causal role for vasopressin (or antidiuretic hormone) in the development of diabetic kidney disease (DKD). Plasma copeptin, the COOH-terminal portion of pre-pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Velho, Gilberto, Ragot, Stéphanie, El Boustany, Ray, Saulnier, Pierre-Jean, Fraty, Mathilde, Mohammedi, Kamel, Fumeron, Frédéric, Potier, Louis, Marre, Michel, Hadjadj, Samy, Roussel, Ronan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071392/ https://www.ncbi.nlm.nih.gov/pubmed/30071874 http://dx.doi.org/10.1186/s12933-018-0753-5

Ejemplares similares

Plasma Copeptin and Renal Outcomes in Patients With Type 2 Diabetes and Albuminuria
por: Velho, Gilberto, et al.
Publicado: (2013)

Lower-extremity amputation as a marker for renal and cardiovascular events and mortality in patients with long standing type 1 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2016)

Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2015)

Manganese Superoxide Dismutase (SOD2) Polymorphisms, Plasma Advanced Oxidation Protein Products (AOPP) Concentration and Risk of Kidney Complications in Subjects with Type 1 Diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2014)

Redox Genetic Risk Score and the Incidence of End-Stage Kidney Disease in People with Type 1 Diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2022)

Leukocyte telomere length, allelic variations in related genes and risk of coronary heart disease in people with long-standing type 1 diabetes
por: Sanchez, Manuel, et al.
Publicado: (2022)

SGLT2 inhibitors and lower limb complications: the diuretic-induced hypovolemia hypothesis
por: Potier, Louis, et al.
Publicado: (2021)

Lower extremity arterial disease in patients with diabetes: a contemporary narrative review
por: Nativel, Mathilde, et al.
Publicado: (2018)

Differential prognostic burden of cardiovascular disease and lower-limb amputation on the risk of all-cause death in people with long-standing type 1 diabetes
por: Camoin, Marion, et al.
Publicado: (2022)

Relationship between cardiac microvascular dysfunction measured with 82Rubidium-PET and albuminuria in patients with diabetes mellitus
por: Potier, Louis, et al.
Publicado: (2018)

Influence of micro- and macro-vascular disease and Tumor Necrosis Factor Receptor 1 on the level of lower-extremity amputation in patients with type 2 diabetes
por: Schneider, Fabrice, et al.
Publicado: (2018)

Urinary Sodium Concentration Is an Independent Predictor of All-Cause and Cardiovascular Mortality in a Type 2 Diabetes Cohort Population
por: Saulnier, Pierre-Jean, et al.
Publicado: (2017)

Prognostic Value of the Insertion/Deletion Polymorphism of the ACE Gene in Type 2 Diabetic Subjects: Results from the Non-Insulin-Dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies
por: Hadjadj, Samy, et al.
Publicado: (2008)

Impact of Natriuretic Peptide Clearance Receptor (NPR3) Gene Variants on Blood Pressure in Type 2 Diabetes
por: Saulnier, Pierre-Jean, et al.
Publicado: (2011)

Body-weight variability and risk of cardiovascular outcomes in patients with type 1 diabetes: a retrospective observational analysis of data from the DCCT/EDIC population
por: Petria, Iulia, et al.
Publicado: (2022)

Paraneoplastic hypoglycemia in a patient with a malignant solitary fibrous tumor
por: Mohammedi, Kamel, et al.
Publicado: (2014)

Increased serum S100A12 levels are associated with higher risk of acute heart failure in patients with type 2 diabetes
por: Gellen, Barnabas, et al.
Publicado: (2022)

History of lower-limb complications and risk of cancer death in people with type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2021)

The evaluation of off-loading using a new removable oRTHOsis in DIABetic foot (ORTHODIAB) randomized controlled trial: study design and rational
por: Mohammedi, Kamel, et al.
Publicado: (2016)

Comparison of a new versus standard removable offloading device in patients with neuropathic diabetic foot ulcers: a French national, multicentre, open-label randomized, controlled trial
por: Potier, Louis, et al.
Publicado: (2020)

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2017)

Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study
por: Mohammedi, Kamel, et al.
Publicado: (2016)

Sex Difference In the Effect of Fetal Exposure to Maternal Diabetes on Insulin Secretion
por: Gautier, Jean-François, et al.
Publicado: (2018)

Copeptin is an independent predictor of diabetic heart disease and death
por: Enhörning, Sofia, et al.
Publicado: (2015)

Association Between Diabetic Macular Edema and Cardiovascular Events in Type 2 Diabetes Patients: A Multicenter Observational Study
por: Leveziel, Nicolas, et al.
Publicado: (2015)

Copeptin: A potential marker for the prediction of poor ovarian reserve in the ınfertile women
por: Görkem, Ümit, et al.
Publicado: (2022)

Prognostic Value of Resting Heart Rate on Cardiovascular and Renal Outcomes in Type 2 Diabetic Patients: A competing risk analysis in a prospective cohort
por: Miot, Aurelie, et al.
Publicado: (2012)

Effects of hydration on plasma copeptin, glycemia and gluco-regulatory hormones: a water intervention in humans
por: Enhörning, Sofia, et al.
Publicado: (2017)

Novel risk genes identified in a genome-wide association study for coronary artery disease in patients with type 1 diabetes
por: Charmet, Romain, et al.
Publicado: (2018)

Fetal Exposure to Maternal Type 1 Diabetes Is Associated With Renal Dysfunction at Adult Age
por: Khalil, Charbel Abi, et al.
Publicado: (2010)

Plasma copeptin levels are inversely associated with intima-media-thickness in men: the population-based KORA F4 study
por: Then, Cornelia, et al.
Publicado: (2013)

Copeptin in anorexia nervosa
por: Goetze, Jens P., et al.
Publicado: (2020)

Associations of microvascular complications with all‐cause death in patients with diabetes and COVID‐19: The CORONADO, ABCD COVID‐19 UK national audit and AMERICADO study groups
por: Hadjadj, Samy, et al.
Publicado: (2022)

New roles for prokineticin 2 in feeding behavior, insulin resistance and type 2 diabetes: Studies in mice and humans
por: Mortreux, Marie, et al.
Publicado: (2019)

Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID‐19 in type 2 diabetes
por: Alzaid, Fawaz, et al.
Publicado: (2020)

What Is the Contribution of Two Genetic Variants Regulating VEGF Levels to Type 2 Diabetes Risk and to Microvascular Complications?
por: Bonnefond, Amélie, et al.
Publicado: (2013)

Copeptin as a Serum Biomarker of Febrile Seizures
por: Stöcklin, Benjamin, et al.
Publicado: (2015)

Copeptin in aneurysmal subarachnoid hemorrhage
por: Tamargo, Rafael J
Publicado: (2012)

Copeptin under glucagon stimulation
por: Lewandowski, Krzysztof C., et al.
Publicado: (2015)

Arginine Vasopressin and Copeptin in Perinatology
por: Evers, Katrina Suzanne, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6f5iss7q9ef6nvnjvqstrmmgg6